Published in Immunology on December 01, 1988
Murine cerebral malaria development is independent of toll-like receptor signaling. Am J Pathol (2007) 1.38
Platelets play an important role in TNF-induced microvascular endothelial cell pathology. Am J Pathol (1997) 1.35
Role of platelet adhesion in homeostasis and immunopathology. Mol Pathol (1997) 1.16
Role of CD40-CVD40L in mouse severe malaria. Am J Pathol (2001) 1.14
An effector role for platelets in systemic and local lipopolysaccharide-induced toxicity in mice, mediated by a CD11a- and CD54-dependent interaction with endothelium. Infect Immun (1993) 1.12
Inhibition of platelet adherence to brain microvasculature protects against severe Plasmodium berghei malaria. Infect Immun (2003) 1.07
Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice. Infect Immun (2000) 1.03
Protein kinase C-theta is required for development of experimental cerebral malaria. Am J Pathol (2010) 0.89
Association of a determinant on mouse chromosome 18 with experimental severe Plasmodium berghei malaria. Infect Immun (2002) 0.88
Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria. PLoS One (2008) 0.88
T-cell-dependent immunity and thrombocytopenia in rats infected with Plasmodium chabaudi. Infect Immun (1992) 0.76
HIV Malaria Co-Infection Is Associated with Atypical Memory B Cell Expansion and a Reduced Antibody Response to a Broad Array of Plasmodium falciparum Antigens in Rwandan Adults. PLoS One (2015) 0.76
Tumour necrosis factor, interleukin-6 and interleukin-10 are possibly involved in Plasmodium vivax-associated thrombocytopaenia in southern Pakistani population. Malar J (2014) 0.75
Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol (1983) 14.36
Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science (1987) 7.01
IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides. J Immunol (1979) 2.86
L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J Immunol (1986) 2.79
Thrombocytopenia in malaria with immunoglobulin (IgM) changes. Br Med J (1972) 2.64
Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94 000 and 180 000 molecular weight. Eur J Immunol (1982) 2.47
The immunological response of CBA mice to P. yoelii. I. General characteristics, the effects of T-cell deprivation and reconstitution with thymus grafts. Immunology (1977) 1.54
Immune-mediated thrombocytopenia of malaria. J Clin Invest (1983) 1.28
Malaria-induced thrombocytopenia. Blut (1981) 1.17
Infection-induced thrombocytopenia. Semin Thromb Hemost (1982) 1.10
Disseminated intravascular coagulation with fatal haemorrhage in cerebral malaria. Br Med J (1970) 0.97
Quantification of platelet-bound IgG by 125I-Staphylococcal protein A in immune thrombocytopenic purpura and other thrombocytopenic disorders. Blood (1984) 0.87
Pathogenesis of the delayed phase of Rauscher virus-induced thrombocytopenia. J Immunol (1986) 0.87
Blood coagulation studies in Plasmodium falciparum malaria. Am J Med Sci (1973) 0.86
The measurement of platelet-bound immunoglobulins: an overview of the methods and the biological relevance of platelet-associated IgG. Prog Hematol (1983) 0.81
The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell (1989) 10.98
Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med (1968) 8.91
Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science (1987) 7.01
Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med (1989) 6.79
Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease. J Clin Invest (1976) 5.96
Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q. J Clin Invest (1974) 5.81
Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med (1988) 4.69
Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethylene glycol. J Immunol (1973) 4.28
Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin-binding test. A comparative study with 125I-labelled Clq binding and Raji-cell RIA tests. Clin Exp Immunol (1977) 3.27
Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci U S A (1989) 3.03
Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. J Clin Invest (1975) 2.97
L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J Immunol (1986) 2.79
Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identificantion of circulating DNA and renal localization of DNA-anti-DNA complexes. J Exp Med (1977) 2.58
Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndrome. N Engl J Med (1990) 2.54
Determination of anti-DNA antibodies by a modified 125I-labelled DNA-binding test. Elimination of non-specific binding of DNA to non-immunoglobulin basic proteins by using an anionic detergent. Clin Exp Immunol (1976) 2.50
Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine (1993) 2.48
Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J (1994) 2.41
Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis (1990) 2.36
Release of DNA in circulating blood and induction of anti-DNA antibodies after injection of bacterial lipopolysaccharides. J Exp Med (1974) 2.34
Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol Rev (1989) 2.22
Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J Clin Invest (1995) 2.20
Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis. Clin Exp Immunol (1984) 2.13
Inhibition of P. falciparum growth in human erythrocytes by monoclonal antibodies. Nature (1981) 2.05
Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity. J Clin Invest (1977) 1.97
Oxygen toxicity in mouse lung: pathways to cell death. Am J Respir Cell Mol Biol (1998) 1.94
Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol (1996) 1.92
Thymus-independent (B) cell proliferation in spleen cell cultures of mouse radiation chimeras stimulated by phytohemagglutinin or allogeneic cells. J Exp Med (1972) 1.90
Comparison of the immune responsiveness of NZB and NZB X NZW F1 hybrid mice with that of other strains of mice. J Exp Med (1969) 1.87
Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol (1991) 1.78
The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines. J Immunol (1986) 1.71
Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol (1998) 1.70
Failure to detect circulating DNA--anti-DNA complexes by four radioimmunological methods in patients with systemic lupus erythematosus. Clin Exp Immunol (1977) 1.66
Immune complexes and complement hypercatabolism in patients with leprosy. Clin Exp Immunol (1976) 1.66
Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology (1992) 1.63
Autoimmune response to DNA, red blood cells, and thymocyte antigens in association with polyclonal antibody synthesis during experimental African trypanosomiasis. J Immunol (1979) 1.60
Genesis of antinuclear antibody in NZB-W mice: role of genetic factors and of viral infections. Clin Exp Immunol (1970) 1.59
Studies on the thymic dependence of the immunoglobulin classes of the mouse (38570). Proc Soc Exp Biol Med (1975) 1.57
TNF-induced microvascular pathology: active role for platelets and importance of the LFA-1/ICAM-1 interaction. Eur Cytokine Netw (1994) 1.56
SDS-PAGE analysis of M. leprae protein antigens reacting with antibodies from sera from lepromatous patients and infected armadillos. Clin Exp Immunol (1982) 1.56
Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children. Am J Trop Med Hyg (1987) 1.55
Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlation with polyclonal B cell activation and with intracerebral immunoglobulin synthesis. J Clin Invest (1981) 1.55
Autoimmunity after induction of neonatal tolerance to alloantigens: role of B cell chimerism and F1 donor B cell activation. J Immunol (1986) 1.54
Vaccination against typhoid fever: present status. Bull World Health Organ (1994) 1.52
Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia. J Exp Med (1990) 1.48
Detection of anti-glomerular basement membrane antibodies by radioimmunological technique. Clinical application in human nephropathies. J Clin Invest (1974) 1.48
Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages. J Immunol (1993) 1.48
Blockade of human P2X7 receptor function with a monoclonal antibody. Blood (1998) 1.45
Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI. J Immunol (1996) 1.43
Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur J Immunol (1991) 1.42
IgG3 is the major source of cryoglobulins in mice. J Immunol (1989) 1.42
Functional analysis of T cell subsets from mice bearing the lpr gene. J Immunol (1985) 1.38
Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect (1999) 1.37
Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin priming. Eur J Immunol (1992) 1.36
Platelets play an important role in TNF-induced microvascular endothelial cell pathology. Am J Pathol (1997) 1.35
Detection of immune complexes in human diseases. Prog Allergy (1978) 1.35
Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. Infect Immun (1994) 1.35
TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53. Eur J Immunol (1998) 1.33
Circulating and tissue-bound immune complex formation in murine malaria. J Immunol (1979) 1.32
A simple automated method for complement estimation in a continuous flow system. J Immunol (1972) 1.30
Immunopathological aspects of Plasmodium berghei infection in five strains of mice. II. Immunopathology of cerebral and other tissue lesions during the infection. Clin Exp Immunol (1980) 1.29
Quantitation of C3PA (properdin factor B) and other complement components in diseases associated with a low C3 level. Clin Immunol Immunopathol (1973) 1.28
The diagnosis of malaria infection using a solid-phase radioimmunoassay for the detection of malaria antigens. Application to the detection of Plasmodium berghei infection in mice. Parasitology (1980) 1.28
Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice. J Immunol (1987) 1.27
Virulent P. berghei malaria: prolonged survival and decreased cerebral pathology in cell-dependent nude mice. J Immunol (1982) 1.26
Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J Clin Invest (1996) 1.25
Comparison of immunological methods for diagnosis of pneumococcal pneumonia in biological fluids. Eur J Clin Microbiol (1987) 1.25
Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis. J Infect Dis (1982) 1.25
Mechanism for induction of anti-DNA antibodies by bacterial lipopolysaccharides in mice. I. Anti-DNA induction by LPS without significant release of DNA in circulating blood. J Immunol (1977) 1.22
Mycobacterial heat-shock proteins as carrier molecules. Eur J Immunol (1991) 1.21
Trypanosoma brucei brucei: a model for cerebral trypanosomiasis in mice--an immunological, histological and electronmicroscopic study. Clin Exp Immunol (1980) 1.20
DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc Natl Acad Sci U S A (1997) 1.20
Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur J Immunol (1998) 1.20
Deposition of idiotype-anti-idiotype immune complexes in renal glomeruli after polyclonal B cell activation. J Exp Med (1982) 1.19
CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming. J Immunol (1999) 1.19
Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice. Am J Pathol (1999) 1.19
The second Geneva Consensus: Recommendations for novel live TB vaccines. Vaccine (2010) 1.18
Dynamics of immune complex nephritis during antibody excess. Int Arch Allergy Appl Immunol (1973) 1.17
In vitro maturation of immature thymocytes into immunocompetent T cells in the absence of direct thymic influence. J Exp Med (1978) 1.17
Purification of bovine conglutinin using pepsin digestion. Mol Immunol (1981) 1.15
Role of CD40-CVD40L in mouse severe malaria. Am J Pathol (2001) 1.14
Decreased capacity to solubilize immune complexes in sera from patients with systemic lupus erythematosus. Arthritis Rheum (1981) 1.14
An anti-idiotype vaccine against experimental schistosomiasis. Nature (1985) 1.13
Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii. Eur J Immunol (1990) 1.12